COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 1713: Articles 17121-17130  | Next

Analysis of the Factors Affecting the Adoption and Compliance of the NHS COVID-19 Mobile Application
Panchal, M., Singh, S., Rodriguez-Villegas, E.
10.1101/2021.03.04.21252924 — Posted: 2021-03-08
An increase in willingness to vaccinate against COVID-19 in the US between October 2020 and February 2021: longitudinal evidence from the Understanding America Study
Daly, M., Jones, A., Robinson, E.
10.1101/2021.03.04.21252918 — Posted: 2021-03-08
A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic
Robinson, E., Sutin, A. R., Daly, M., Jones, A.
10.1101/2021.03.04.21252921 — Posted: 2021-03-08
Trends in SARS-CoV-2 detection during social relaxation measures over ten months of COVID-19 pandemic in the metropolitan area of Rio de Janeiro, Brazil
Alonso, F. d. O. M., Sabino, B. D., de Oliveira, M. C., Knackfuss, F. B., Varella, R.
10.1101/2021.03.02.21252759 — Posted: 2021-03-08
Predictive Capacity of COVID-19 Test Positivity Rate
Fenga, L., Gaspari, M.
10.1101/2021.03.04.21252897 — Posted: 2021-03-08
Development and Implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities
Ceci, A., Munoz-Ballester, C., Tegge, A., Brown, K. L., Umans, R. A., Michel, F. M., Patel, D., Tewari, B., Martin, J., Alcoreza, O., Maynard, T., Martinez-Martinez, D., Bordwine, P., Bisell, N., Friedlander, M., Sontheimer, H., Finkielstein, C. V.
10.1101/2021.03.01.21252679 — Posted: 2021-03-08
Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study
Mikhaylov, E. N., Lyubimtseva, T. A., Vakhrushev, A. D., Stepanov, D., Lebedev, D. S., Vasilieva, E. Y., Konradi, A. O., Shlyakhto, E. V.
10.1101/2021.03.03.21252855 — Posted: 2021-03-08 Discussion: Onsite
Estimation and optimal control of the multi-scale dynamics of the Covid-19
FOTSA MBOGNE, D. J., TCHOUMI, S. Y., Kouakep Tchaptchie, Y., KAMLA, V. C., KAMGANG, J. C., HOUPA DANGA, D. E., BOWONG TSAKOU, S., BEKOLLE, D.
10.1101/2021.03.04.21252880 — Posted: 2021-03-08
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected persons
Demonbreun, A. R., Sancilio, A., Velez, M. E., Ryan, D. T., Saber, R., Vaught, L. A., Reiser, N. L., D'Aquila, R. T., Mustanski, B., McNally, E. M., McDade, T. W.
10.1101/2021.03.04.21252913 — Posted: 2021-03-08
Estimating the super-spreading rate at workplaces using bluetooth technology
Vazquez, A., Staebler, M., Khanin, A., Lichte, D., Brucherseifer, E.
10.1101/2021.03.04.21252550 — Posted: 2021-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).